Description

U.S. Food and Drug Administration officials said Heimlich's so-called "malariatherapy" ; was "not an acceptable treatment or therapy."

Heimlich, contacted yesterday at his home in Cincinnati, said that describing his work as south-of-the-border research…is despicable." He said cancer research regulations in Mexico were more stringent than those in the United States.